Male Androgenetic Alopecia: Response to Finasteride

The study evaluated the efficacy and safety of oral finasteride in treating androgenetic alopecia (AGA) in 40 male patients aged 18-35 over 9 months. Administering 1 mg/day of finasteride showed significant improvement in hair growth, as evidenced by clinical photographs, trichogram results, hair pull tests, and patient self-assessments. Improvements were noted as early as 3 months, with the most benefit observed in the mid-area, followed by the vertex and frontal areas. The study found no significant side effects, concluding that finasteride was a safe, well-tolerated, and effective treatment for male AGA.